(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 6. Exchange dynamics of SP100 and SP100 mutant constructs at NBs. (A) Schematic depiction of SP100 protein and mutants used for FRAP analyses. The oligomerization and PML NB targeting resides within a region spanning amino acids 29-152 of SP100 (Negorev et al., 2001). SP100 has a SUMOylation site at Lys297 (S) within the HP1-binding motif and a nuclear localization signal at the C-terminus (NLS). Note, that SP100 variants that lack the endogenous NLS were engineered to contain one at their N-termini (Negorev et al., 2001). (B) FRAP experiments were performed in U-2 OS cells that express GFP-tagged SP100 wild-type (aa 1-480) and the indicated variants, by bleaching areas that contain NBs and by monitoring fluorescence recovery for various intervals as indicated. Scale bars, 5 µm. (C,D) Quantification of FRAP experiments as shown in B. Graphs show mean values (± s.d.) from at least 20 FRAP experiments. For comparison, the FRAP curve of GFP–PML-IV at NBs was included in C.